VET 0.00% 12.0¢ vocation limited

Valuation, page-4

  1. 54 Posts.
    The fine print…

    Excluding the impact of any potential asset sales, the Company expects
    to generate an Underlying EBITDA of circa $10 million in 2H 15


    With $75-$100M of businesses sold off it will dilute to somewhere closer to $3-$5M? ongoing presumably – so closer to $6-$10M FY
    Sill undervalued, but the litigation hanging over keeping SP down
 
watchlist Created with Sketch. Add VET (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.